Family Legacy Inc. boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.1% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,537 shares of the pharmacy operator’s stock after acquiring an additional 285 shares during the period. Family Legacy Inc.’s holdings in Walgreens Boots Alliance were worth $747,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Hudock Capital Group LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after purchasing an additional 5 shares during the period. Tarbox Group Inc. increased its stake in shares of Walgreens Boots Alliance by 288.3% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock valued at $113,000 after purchasing an additional 1,006 shares during the period. Webster Bank N. A. increased its stake in shares of Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after purchasing an additional 235 shares during the period. MCF Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 68.2% in the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after purchasing an additional 780 shares during the period. Finally, Founders Capital Management acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $161,000. 60.16% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Family Legacy Inc. Acquires 285 Shares of Walgreens Boots Alliance, Inc. (WBA)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/20/family-legacy-inc-acquires-285-shares-of-walgreens-boots-alliance-inc-wba.html.

Several equities research analysts have commented on the stock. Royal Bank Of Canada assumed coverage on shares of Walgreens Boots Alliance in a research note on Tuesday. They issued an “outperform” rating and a $96.00 price target on the stock. Needham & Company LLC restated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Saturday. BidaskClub lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Jefferies Group LLC restated a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, Loop Capital initiated coverage on shares of Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and fifteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $92.06.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 13.50% of the stock is currently owned by corporate insiders.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 0.11% during trading on Wednesday, reaching $81.12. 1,903,924 shares of the company were exchanged. The firm has a 50-day moving average of $81.36 and a 200-day moving average of $81.86. The firm has a market cap of $86.81 billion, a price-to-earnings ratio of 20.48 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. During the same quarter in the prior year, the firm earned $1.18 earnings per share. The business’s quarterly revenue was up 2.1% on a year-over-year basis. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.97%. The ex-dividend date of this dividend was Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.

Walgreens Boots Alliance declared that its board has authorized a stock buyback plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.